SUN-LB075 Effects of Pegvisomant and Pasireotide LAR on Incidence of Vertebral Fractures in Patients with Acromegaly Resistant to Treatment with First-Line Somatostatin Analogs

Purpose: Osteopathy is an emerging complication of acromegaly characterized by increased bone turnover, deterioration in bone microarchitecture and high risk of vertebral fractures (VFs). In somatostatin analog (SSA)- resistant patients (pts), Pegvisomant (PegV) and Pasireotide LAR (Pasi) are used f...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :J Endocr Soc
Главные авторы: Chiloiro, Sabrina, Giampietro, Antonella, Bianchi, Antonio, Bima, Chiara, Frara, Stefano, Mirra, Federica, Donfrancesco, Federico, Fleseriu, Maria, Pontecorvi, Alfredo, Giustina, Andrea, De Marinis, Laura
Формат: Artigo
Язык:Inglês
Опубликовано: Endocrine Society 2019
Предметы:
Neuroendocrinology and Pituitary
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6553164/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/js.2019-SUN-LB075
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы